Pulse Wave Velocity Is Inversely Related to Vertebral Bone Density in Hemodialysis Patients

Abnormalities of bone mineral metabolism in patients with stage-5 chronic kidney disease may contribute to the high incidence of cardiovascular disease. Noninvasive imaging methods may help predict the simultaneous presence of vasculopathy and bone disease. Accordingly, we measured pulse wave velocity and bone mineral density (BMD), and T-scores (number of SDs below the BMD of a younger reference group) of the spine by both dual energy x-ray absorptiometry and quantitative computed tomography (QCT) in 110 maintenance hemodialysis patients. Older age, white race, diabetes mellitus, lower diastolic blood pressure, and lower albumin levels were associated with lower QCT-assessed T-scores (each P<0.05). After age and multivariable adjustment, pulse wave velocity (PWV) increased as QCT BMD decreased (the prevalence of PWV ≥9 m/s was 32.4%, 61.8%, and 76.5% for participants in the highest to the lowest tertile of QCT-assessed BMD; P<0.001). In contrast, there was no relationship between spine dual energy x-ray absorptiometry-BMD and PWV. In unadjusted models, thoracic spine QCT-assessed T-scores correlated significantly, albeit weakly, with aorta calcification (r=0.22; P=0.01) but not with coronary calcification. The odds ratio of PWV ≥9 m/s for patients taking vitamin D3 or its analogs was 0.51 (95% CI: 0.19 to 1.39). In conclusion, low spine BMD is associated with increased PWV in stage-5 chronic kidney disease, supporting the notion of a close interaction of vascular and bone disease in this patient group. QCT and not dual energy x-ray absorptiometry should be used to assess spine BMD in dialysis patients.

[1]  R. Detrano,et al.  Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.

[2]  E. Zeitler,et al.  Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  D. Kiel,et al.  New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. , 1997, Atherosclerosis.

[4]  H. Genant,et al.  Diagnosis and Management of Osteoporosis: Guidelines for the Utilization of Bone Densitometry , 1997, Calcified Tissue International.

[5]  J. Blacher,et al.  Impact of aortic stiffness on survival in end-stage renal disease. , 1999, Circulation.

[6]  A. Farzaneh-Far,et al.  Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  G. London,et al.  Arterial stiffening and vascular calcifications in end-stage renal disease. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  R. Elashoff,et al.  Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. , 2000, The New England journal of medicine.

[9]  M. McKee,et al.  Phosphate regulation of vascular smooth muscle cell calcification. , 2000, Circulation research.

[10]  L. Adrienne Cupples,et al.  Abdominal Aortic Calcific Deposits Are an Important Predictor of Vascular Morbidity and Mortality , 2001, Circulation.

[11]  J. Blacher,et al.  Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease , 2001, Hypertension.

[12]  P. Raggi,et al.  Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. , 2002, Kidney international.

[13]  P. Raggi,et al.  Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? , 2002, Journal of the American College of Cardiology.

[14]  Sharon M Moe,et al.  Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. , 2002, Kidney international.

[15]  H. Malluche,et al.  Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease. , 2003, Kidney international.

[16]  M. Taal,et al.  Total hip bone mass predicts survival in chronic hemodialysis patients. , 2003, Kidney international.

[17]  D. Kiel,et al.  Metacarpal cortical area and risk of coronary heart disease: the Framingham Study. , 2004, American journal of epidemiology.

[18]  L. Labree,et al.  Validation of Thoracic Quantitative Computed Tomography as a Method to Measure Bone Mineral Density , 2004, Calcified Tissue International.

[19]  Carl D Langefeld,et al.  Measurement of Trabecular Bone Mineral Density in the Thoracic Spine Using Cardiac Gated Quantitative Computed Tomography , 2004, Journal of computer assisted tomography.

[20]  G. London,et al.  Arterial calcifications and bone histomorphometry in end-stage renal disease. , 2004, Journal of the American Society of Nephrology : JASN.

[21]  L. Schurgers,et al.  Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. , 2004, Journal of the American Society of Nephrology : JASN.

[22]  J. Sayre,et al.  Aortic calcification and the risk of osteoporosis and fractures. , 2004, The Journal of clinical endocrinology and metabolism.

[23]  A. Murray,et al.  Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. , 2005, Journal of the American Society of Nephrology : JASN.

[24]  P. Raggi,et al.  Decrease in Thoracic Vertebral Bone Attenuation With Calcium‐Based Phosphate Binders in Hemodialysis , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  J. Magnus,et al.  Relationship between bone mineral density and myocardial infarction in US adults , 2005, Osteoporosis International.

[26]  G. Eknoyan,et al.  Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2006, Kidney international.

[27]  P. Raggi,et al.  Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients. , 2006, Kidney international.

[28]  G. London,et al.  Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. , 2007, Journal of the American Society of Nephrology : JASN.